MedTrace Logo

Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy

NCT01645098 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2015-02-26

Study results available
· View outcomes & findings →

Summary

This is an interventional study on Duchenne muscular dystrophy patients who will be receiving sedation for a muscle biopsy as part of another study.

Conditions

Interventions

DRUG

Ketamine

1 mg/kg IV, additional doses of 0.5 mg/kg as needed

DRUG

Dexmedetomidine

0.5 mcg/kg/hr IV

Sponsors & Collaborators

  • Nationwide Children's Hospital

    lead OTHER

Principal Investigators

  • Joseph D Tobias, MD · Nationwide Children's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-04-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645098 on ClinicalTrials.gov